Neurocrine Biosciences' GAAP net income for 2021 was $89.6 million, down 4.5 times from $407.3 million in the previous year. Revenue increased 8.4% to $1.134 billion from $1.046 billion a year earlier.
Neurocrine Biosciences' GAAP net income for 2021 was $89.6 million, down 4.5 times from $407.3 million in the previous year. Revenue increased 8.4% to $1.134 billion from $1.046 billion a year earlier. 
neurocrine.gcs-web.com
English (US) 